Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angeliki Angelidi

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Clinics and Practice|April 26, 2014
Acute steatohepatitis, due to extreme metabolic dysregulation, as the first presentation of non-alcoholic fatty liver diseaseGeorgios Kranidiotis, Angeliki Angelidi, Emmanouel Sevdalis, et al.
Diabetes Technology & Therapeutics|February 11, 2016
The Impact of Continuous Subcutaneous Insulin Infusion Therapy on Efficacy and Safety in a Cohort of Type 1 Diabetes Patients: A 3-Year Prospective StudyAndreas Melidonis, Alexandros Kamaratos, Angeliki Angelidi, et al.
The American Journal of Medicine|August 25, 2009
More than skin deepIoannis Protopsaltis, Angeliki Angelidi, Haralampos J Milionis, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|January 15, 2017
Predictors of left ventricular diastolic dysfunction in type 2 diabetes patients: A 4-year prospective studyEvangelos Fousteris, Athanasia Papazafiropoulou, Christos Tountas, et al.
Hormones (Athens, Greece)|April 30, 2014
Endothelial progenitor cells as a cardiometabolic risk factor marker in prediabetesAngeliki Angelidi, Andreas Melidonis, Ioannis Protopsaltis, et al.
Cardiovascular Diabetology|November 17, 2012
Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individualsIoannis Protopsaltis, Stefanos Foussas, Angeliki Angelidi, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Clinics and Practice|April 26, 2014
Acute steatohepatitis, due to extreme metabolic dysregulation, as the first presentation of non-alcoholic fatty liver diseaseGeorgios Kranidiotis, Angeliki Angelidi, Emmanouel Sevdalis, et al.
Diabetes Technology & Therapeutics|February 11, 2016
The Impact of Continuous Subcutaneous Insulin Infusion Therapy on Efficacy and Safety in a Cohort of Type 1 Diabetes Patients: A 3-Year Prospective StudyAndreas Melidonis, Alexandros Kamaratos, Angeliki Angelidi, et al.
The American Journal of Medicine|August 25, 2009
More than skin deepIoannis Protopsaltis, Angeliki Angelidi, Haralampos J Milionis, et al.
Hellenic Journal of Cardiology : HJC = Hellenike Kardiologike Epitheorese|January 15, 2017
Predictors of left ventricular diastolic dysfunction in type 2 diabetes patients: A 4-year prospective studyEvangelos Fousteris, Athanasia Papazafiropoulou, Christos Tountas, et al.
Hormones (Athens, Greece)|April 30, 2014
Endothelial progenitor cells as a cardiometabolic risk factor marker in prediabetesAngeliki Angelidi, Andreas Melidonis, Ioannis Protopsaltis, et al.
Cardiovascular Diabetology|November 17, 2012
Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individualsIoannis Protopsaltis, Stefanos Foussas, Angeliki Angelidi, et al.
Pageof 1